Copyright
©The Author(s) 2023.
World J Cardiol. Sep 26, 2023; 15(9): 427-438
Published online Sep 26, 2023. doi: 10.4330/wjc.v15.i9.427
Published online Sep 26, 2023. doi: 10.4330/wjc.v15.i9.427
Figure 1 Kaplan Meier.
A: Remdesivir use and mortality in patients with troponin elevation; B: Dexamethasone use and mortality in patients with troponin elevation; C: Angiotensin-converting enzyme inhibitors use and mortality in patients with troponin elevation. ACEI: Angiotensin-converting enzyme inhibitors.
- Citation: Umeh CA, Maoz H, Obi J, Dakoria R, Patel S, Maity G, Barve P. Remdesivir, dexamethasone and angiotensin-converting enzyme inhibitors use and mortality outcomes in COVID-19 patients with concomitant troponin elevation. World J Cardiol 2023; 15(9): 427-438
- URL: https://www.wjgnet.com/1949-8462/full/v15/i9/427.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i9.427